We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUR icon
201
Aurora
AUR
$13.3B
$4.94M 0.04%
+500,326
New +$4.96M
LUCK
202
Lucky Strike Entertainment
LUCK
$911M
$4.94M 0.04%
+500,326
New +$4.9M
WPCB
203
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$4.94M 0.04%
+500,326
New +$4.93M
SVFA
204
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$4.94M 0.04%
+499,982
New +$5.03M
LOCL icon
205
Local Bounti
LOCL
$22.3M
$4.93M 0.04%
+38,431
New +$4.91M
CCVI
206
DELISTED
Churchill Capital Corp VI
CCVI
$4.93M 0.04%
+500,000
New +$4.96M
BTAQ
207
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
$4.92M 0.04%
499,982
FCAX
208
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$4.92M 0.04%
499,982
EQD
209
DELISTED
Equity Distribution Acquisition Corp.
EQD
$4.92M 0.04%
498,993
-225,881
-31% -$2.23M
OPAL icon
210
OPAL Fuels
OPAL
$72.6M
$4.92M 0.04%
+500,000
New +$4.92M
KAHC
211
DELISTED
KKR Acquisition Holdings I Corp.
KAHC
$4.91M 0.04%
+500,326
New +$4.89M
MVLA
212
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$4.9M 0.04%
+500,000
New +$4.92M
VPCB
213
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$4.9M 0.04%
+501,305
New +$4.92M
CPUH
214
DELISTED
Compute Health Acquisition Corp.
CPUH
$4.9M 0.04%
+498,993
New +$4.9M
PCPC
215
DELISTED
Periphas Capital Partnering Corporation
PCPC
$4.9M 0.04%
199,893
IRT icon
216
Independence Realty Trust
IRT
$4B
$4.9M 0.04%
268,700
+38,300
+17% +$650K
GROV icon
217
Grove Collaborative
GROV
$47.1M
$4.89M 0.04%
+100,000
New +$4.91M
GLS
218
DELISTED
Gelesis Holdings, Inc.
GLS
$4.89M 0.04%
499,982
PIAI
219
DELISTED
Prime Impact Acquisition I
PIAI
$4.89M 0.04%
501,958
CSTA
220
DELISTED
Constellation Acquisition Corp I
CSTA
$4.89M 0.04%
499,587
-100,391
-17% -$984K
GNAC
221
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
$4.89M 0.04%
499,982
GOAC
222
DELISTED
GO Acquisition Corp. Class A Common Stock
GOAC
$4.89M 0.04%
499,982
SQM icon
223
Sociedad Química y Minera de Chile
SQM
$20.7B
$4.89M 0.04%
+103,270
New +$5.09M
CLAA
224
DELISTED
Colonnade Acquisition Corp. II
CLAA
$4.89M 0.04%
+500,326
New +$4.9M
FRGE
225
DELISTED
Forge Global Holdings
FRGE
$4.88M 0.04%
33,332

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.